Bionano Genomics, Inc. (BNGO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
28/75
1.9 / 5 stars
All 75 Win/Lose results and 45 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBNGO / S&P -3.42% / 15.20% |
LoseBNGO / S&P 10.03% / 15.00% |
LoseBNGO / S&P -92.81% / 50.40% |
| 2026-Q10/3 |
LoseBNGO / S&P -23.53% / -4.33% |
LoseBNGO / S&P 0.96% / 11.30% |
LoseBNGO / S&P -91.97% / 27.70% |
| 2025-Q40/3 |
LoseBNGO / S&P -10.53% / 2.65% |
LoseBNGO / S&P -7.37% / 9.00% |
LoseBNGO / S&P -94.65% / 13.40% |
| 2025-Q30/3 |
LoseBNGO / S&P -47.87% / 8.12% |
LoseBNGO / S&P -13.84% / 4.61% |
LoseBNGO / S&P -97.38% / 13.45% |
| 2025-Q21/3 |
WinBNGO / S&P 17.56% / 10.94% |
LoseBNGO / S&P -25.02% / 4.83% |
LoseBNGO / S&P -90.79% / 10.63% |
| 2025-Q10/3 |
LoseBNGO / S&P -83.97% / -4.27% |
LoseBNGO / S&P -24.04% / 4.98% |
LoseBNGO / S&P -87.71% / 10.57% |
| 2024-Q40/3 |
LoseBNGO / S&P -35.56% / 2.41% |
LoseBNGO / S&P -14.79% / 5.25% |
LoseBNGO / S&P -78.20% / 6.15% |
| 2024-Q31/3 |
LoseBNGO / S&P -33.82% / 5.89% |
LoseBNGO / S&P -0.82% / 5.89% |
WinBNGO / S&P 6821.75% / 6.11% |
| 2024-Q22/3 |
LoseBNGO / S&P -38.74% / 4.28% |
WinBNGO / S&P 16.08% / 5.38% |
WinBNGO / S&P 9266.12% / 5.12% |
| 2024-Q12/3 |
LoseBNGO / S&P -41.27% / 10.56% |
WinBNGO / S&P 26.93% / 5.71% |
WinBNGO / S&P 9205.88% / 5.59% |
| 2023-Q42/3 |
LoseBNGO / S&P -37.62% / 11.69% |
WinBNGO / S&P 29.90% / 6.81% |
WinBNGO / S&P 11120.88% / 7.78% |
| 2023-Q32/3 |
LoseBNGO / S&P -50.33% / -3.27% |
WinBNGO / S&P 29.82% / 7.52% |
WinBNGO / S&P 188.84% / -5.03% |
| 2023-Q22/3 |
LoseBNGO / S&P -45.05% / 8.74% |
WinBNGO / S&P 35.12% / 9.50% |
WinBNGO / S&P 250.36% / -8.57% |
| 2023-Q12/3 |
LoseBNGO / S&P -23.97% / 7.50% |
WinBNGO / S&P 43.94% / 10.77% |
WinBNGO / S&P 1342.42% / -15.69% |
| 2022-Q42/3 |
LoseBNGO / S&P -20.22% / 7.56% |
WinBNGO / S&P 54.62% / 11.88% |
WinBNGO / S&P 1300.00% / -17.99% |
| 2022-Q32/2 |
WinBNGO / S&P 32.61% / -4.88% |
WinBNGO / S&P 65.22% / 13.47% |
No dataBNGO / S&P / -1.41% |
| 2022-Q21/2 |
LoseBNGO / S&P -46.51% / -16.10% |
WinBNGO / S&P 76.56% / 13.71% |
No dataBNGO / S&P / 11.04% |
| 2022-Q11/2 |
LoseBNGO / S&P -13.71% / -4.60% |
WinBNGO / S&P 94.66% / 15.97% |
No dataBNGO / S&P / 42.23% |
| 2021-Q41/2 |
LoseBNGO / S&P -45.64% / 11.03% |
WinBNGO / S&P 111.44% / 15.00% |
No dataBNGO / S&P / 96.40% |
| 2021-Q31/2 |
LoseBNGO / S&P -24.97% / 0.58% |
WinBNGO / S&P 114.54% / 10.77% |
No dataBNGO / S&P / 69.42% |
| 2021-Q21/2 |
LoseBNGO / S&P -9.28% / 8.55% |
WinBNGO / S&P 56.88% / 6.58% |
No dataBNGO / S&P / 51.81% |
| 2021-Q12/2 |
WinBNGO / S&P 162.34% / 6.17% |
WinBNGO / S&P 11.92% / -1.06% |
No dataBNGO / S&P / 7.39% |
| 2020-Q41/2 |
WinBNGO / S&P 373.85% / 12.15% |
LoseBNGO / S&P -16.06% / -3.72% |
No dataBNGO / S&P / -33.42% |
| 2020-Q31/2 |
WinBNGO / S&P 27.45% / 8.93% |
LoseBNGO / S&P -35.68% / -2.04% |
No dataBNGO / S&P / -27.10% |
| 2020-Q20/2 |
LoseBNGO / S&P 10.87% / 20.54% |
LoseBNGO / S&P -22.54% / -0.46% |
No dataBNGO / S&P / -27.11% |
| 2020-Q10/2 |
LoseBNGO / S&P -62.90% / -19.60% |
LoseBNGO / S&P -22.11% / 3.47% |
No dataBNGO / S&P / -14.75% |
| 2019-Q41/2 |
WinBNGO / S&P 72.22% / 9.07% |
LoseBNGO / S&P -15.58% / 5.36% |
No dataBNGO / S&P / 2.99% |
| 2019-Q30/2 |
LoseBNGO / S&P -70.61% / 1.70% |
LoseBNGO / S&P 4.82% / 5.02% |
No dataBNGO / S&P / 0.21% |
| 2019-Q20/2 |
LoseBNGO / S&P -43.81% / 4.30% |
LoseBNGO / S&P 1.15% / 6.64% |
No dataBNGO / S&P / 8.65% |
| 2019-Q10/1 |
LoseBNGO / S&P -16.79% / 13.65% |
No dataBNGO / S&P / 8.12% |
No dataBNGO / S&P / 14.29% |
| 2018-Q40/1 |
LoseBNGO / S&P -34.17% / -13.52% |
No dataBNGO / S&P / 9.05% |
No dataBNGO / S&P / 18.23% |
| 2018-Q30/0 |
No dataBNGO / S&P / 7.71% |
No dataBNGO / S&P / 10.21% |
No dataBNGO / S&P / 19.06% |
| 2018-Q20/0 |
No dataBNGO / S&P / 3.43% |
No dataBNGO / S&P / 9.03% |
No dataBNGO / S&P / 14.46% |
| 2018-Q10/0 |
No dataBNGO / S&P / -0.76% |
No dataBNGO / S&P / 7.68% |
No dataBNGO / S&P / 12.46% |
| 2017-Q40/0 |
No dataBNGO / S&P / 6.64% |
No dataBNGO / S&P / 7.03% |
No dataBNGO / S&P / 13.82% |
| 2017-Q30/0 |
No dataBNGO / S&P / 4.48% |
No dataBNGO / S&P / 5.68% |
No dataBNGO / S&P / 17.57% |
| 2017-Q20/0 |
No dataBNGO / S&P / 3.09% |
No dataBNGO / S&P / 4.83% |
No dataBNGO / S&P / 17.74% |
| 2017-Q10/0 |
No dataBNGO / S&P / 6.07% |
No dataBNGO / S&P / 3.67% |
No dataBNGO / S&P / 13.32% |
| 2016-Q40/0 |
No dataBNGO / S&P / 3.82% |
No dataBNGO / S&P / 2.09% |
No dataBNGO / S&P / 7.05% |
| 2016-Q30/0 |
No dataBNGO / S&P / 3.85% |
No dataBNGO / S&P / 0.20% |
No dataBNGO / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BNGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -67.90% | 20.78% |
| Annualized return | -67.90% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BNGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.97% | 83.14% |
| Annualized return | -79.73% | 12.86% |
10Y · 2018-08-21 to 2026-08-27
| Metric | BNGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.97% | 319.30% |
| Annualized return | -55.17% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |